Living with Elevated Lipoprotein(a) Levels: The Experiences of Patients and Caregivers
Elevated Lp(a) was considered an "invisible" disorder with limited understanding among physicians and the general public. This reduces access to tests and shifts physician focus away from prevention towards reactive intervention.
Authors
- Magdalena Daccord
- Flavia Perna
- Elisabeth Steinhagen‐Thiessen (ORCID: https://orcid.org/0000-0003-3056-3317)
- Janine L. Shipton
- Yujiao Wang (ORCID: https://orcid.org/0009-0006-4102-5804)
- India Rijken
- Michael Shipton
- Matthias Schoenberger
- Emma C Print
Institutions
- Novartis (Switzerland) (CH)
- Swiss School of Public Health (CH)
- Canon Foundation in Europe (NL)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Patient Preference and Adherence
- Published
- 2025-02-01
- DOI
- https://doi.org/10.2147/ppa.s478623
- Citations
- 1
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- Novartis Pharma